Establishment of a hepatocellular carcinoma patient‐derived xenograft platform and its application in biomarker identification-Reference-Cited by-同舟云学术

Establishment of a hepatocellular carcinoma patient‐derived xenograft platform and its application in biomarker identification

Published:2019-08-09 Issue:6 Volume:146 Page:1606-1617
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Hu Bo¹²,Li Hong³,Guo Wei¹²⁴,Sun Yun‐Fan¹²,Zhang Xin¹²,Tang Wei‐Guo¹²,Yang Liu‐Xiao¹²,Xu Yang¹²,Tang Xiao‐Yan³,Ding Guo‐Hui³,Qiu Shuang‐Jian¹²,Zhou Jian¹²⁵,Li Yi‐Xue³,Fan Jia¹²⁵,Yang Xin‐Rong¹²^ORCID

Affiliation:

1. Department of Liver Surgery, Liver Cancer Institute, Zhongshan HospitalFudan University Shanghai People's Republic of China

2. Key Laboratory of Carcinogenesis and Cancer InvasionMinistry of Education Shanghai People's Republic of China

3. Key Laboratory of Computational Biology, CAS‐MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological SciencesChinese Academy of Sciences Shanghai People's Republic of China

4. Department of Laboratory Medicine, Zhongshan HospitalFudan University Shanghai People's Republic of China

5. Institute of Biomedical SciencesFudan University Shanghai People's Republic of China

Funder

National High-tech Research and Development Program

National Natural Science Foundation of China

Shanghai Municipal Science and Technology Commission

Chinese Academy of Sciences

Publisher

Wiley

Subject

Cancer Research,Oncology

Link